VANCOUVER, June 23 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced
today that it has opened a Center for Colorectal Health in San Diego CA. This
Center is the Company's third in the state of California, one of many markets
that CRH has targeted for expansion. The opening of this location represents
the 7th new Center opened in 2008 bringing the Company's total number of
Centers to 15.
According to the National Institute of Health, the prevalence rate of
hemorrhoids in the US is about 4.4% of the population. Approximately 50% of
the U.S. population will develop hemorrhoids by age 50. The Company plans to
significantly increase the number of Centers for Colorectal Health across the
U.S. to address this underserved market.
About CRH Medical Corporation:
CRH Medical Corporation specializes in the treatment of hemorrhoids
utilizing its proven treatment protocol and patented proprietary technology.
CRH's single use, disposable, hemorrhoid technology is safe and highly
effective in treating hemorrhoid grades I - IV. CRH Medical employs two
commercialization strategies: First, it operates Centers for Colorectal Health
facilities in the United States specializing in the treatment of hemorrhoids
and fissures, and colon cancer screening. In addition CRH distributes its
hemorrhoid banding technology, treatment protocols, operational and marketing
expertise as a complete, "turn key" package directly to its partner
physicians. The Company's goal is to establish the CRH hemorrhoid technology
as the standard for hemorrhoid treatment.
The information in this news release contains so-called "forward-looking"
statements. These include statements regarding CRH Medical expectations,
beliefs, intentions or strategies for the future, which may be indicated by
words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we
believe", "CRH Medical believes", "management believes" and similar language.
All forward-looking statements are based on CRH Medical current expectations
and are subject to risks and uncertainties and to assumptions made.
Additional information may also be found by visiting the Company's
website at www.crhmedcorp.com or the SEDAR website at www.sedar.com.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
For further information:
For further information: Dean Linden, Investor Relations, CRH Medical
Corporation, (604) 633-1440, firstname.lastname@example.org